Hearing aids are the most commonly us treatment for people with age-relat hearing loss, however, hearing aid uptake is low, primarily due to high cost of the device, stigma, and a lack of perceiv ne. To address accessibility and affordability issues, the U.S. Food and Drug Administration creat a new over-the-counter (OTC) hearing aid category. Various types of hearing devices are available for both individuals with hearing loss and for those with normal hearing, as hearing enhancement devices. Hearing aids (i.e., prescription hearing aids, self-fitting OTC hearing aids, and pre-set OTC hearing aids) are regulat by the FDA.
To Achieve The Specifi Missions
The purpose of this article is to (a) provide a summary of existing research on direct-to-consumer (DTC) hearing devices such as Personal Sound Amplification Products (PSAPs) that informs OTC service delivery models; (b) provide an update on existing and ongoing randomiz controll trials on currently market OTC hearing aids; and (c) highlight the ne for immiate research on OTC hearing aids and service delivery models to inform policy and clinical care. It remains to seen what effect OTC hearing Dominican Republic Email List aids have on improving the uptake of hearing aids by individuals with mild-to-moderate hearing loss. However, there is scant research on all aspects of OTC hearing aids that are currently on the market. We conclude that high quality independent research must prioritiz to supplement evidence provid by the OTC hearing aid manufacturers for regulatory approval purposes.
Manuscripts Of All Types That Make
Introduction Aging is the leading cause of hearing loss which affects an estimat 1.5 billion persons globally and age-relat hearing loss is one of the most common chronic health conditions affecting nearly one third of the world’s population over 60 years (World Health Organization, 2021). Age-relat hearing loss has various physical, cognitive TH Lists and emotional consequences including structural and functional changes to the brain (Glick and Sharma, 2020; Slade et al., 2020). Hearing aids are the most commonly us treatment for people with hearing loss and the 2020 Lancet Commission on.